… of this review is to reveal the latest findings regarding foetal diagnosis and perinatal
management in OI, with the hope that it will help in perinatal care medicine. This review provides an …

… current treatment modalities and an update … management of OI has been reviewed extensively
elsewhere (9, 49, 50, 51, 52), so this review provides a brief update on current treatment …

… Glorieaux and his team published updated reports on the use of pamidronate, a
bisphosphonate given by IV in an OI-controlled study and noted a decrease in fracture frequency, …

… · Therapeutic management of osteogenesis imperfecta has become increasingly challenging
because of advances in the genetic understanding of existing phenotypes and newly …

… Bisphosphonates in Osteogenesis Imperfecta Bisphosphonates are the most widely used
agents for the treatment of osteogenesis imperfecta. In the present review, I will review the …

… The latest accepted classification was proposed by Botor et al. in 2021 and … management
strategies for therapeutic efficacy is difficult to conduct and was not the aim of this current review…

… In this review, we discuss current treatment options and provide insights into upcoming
OI therapies mostly based on genetic engineering and stem cell transplantation. …

… In this review, we gave an update on animal models that recapitulate OI with a focus on
engineered mouse and zebrafish models (Tables 2 and 3) according to possible mechanisms, …

… Osteogenesis Imperfecta (OI) is a genetic disorder also known as ‘brittle bone disease’ …
I collagen synthesis have been shown to cause osteogenesis imperfecta [5]. The current non-…

… Osteogenesis imperfecta (OI) is a disease encompassing a group of disorders mainly
characterized by bone … Sign up today to receive the latest news and updates from UpToDate. …